Cargando…

Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01

BACKGROUND: β-Galactooligosaccharides (GOS) are typically used in infant formula and adult nutritionals as a source of nondigestible oligosaccharides, which may bring beneficial effects through modulation of the gut microbiota. However, suitable methods for the determination of GOS in products with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuany, Denis, Andetsion, Fikrey, Fontannaz, Xavier, Bénet, Thierry, Spichtig, Véronique, Austin, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824811/
https://www.ncbi.nlm.nih.gov/pubmed/34293126
http://dx.doi.org/10.1093/jaoacint/qsab095
_version_ 1784647079506739200
author Cuany, Denis
Andetsion, Fikrey
Fontannaz, Xavier
Bénet, Thierry
Spichtig, Véronique
Austin, Sean
author_facet Cuany, Denis
Andetsion, Fikrey
Fontannaz, Xavier
Bénet, Thierry
Spichtig, Véronique
Austin, Sean
author_sort Cuany, Denis
collection PubMed
description BACKGROUND: β-Galactooligosaccharides (GOS) are typically used in infant formula and adult nutritionals as a source of nondigestible oligosaccharides, which may bring beneficial effects through modulation of the gut microbiota. However, suitable methods for the determination of GOS in products with a high background of lactose do not exist. OBJECTIVE: The aim of this work was to develop a method suitable for the determination of GOS in infant formula and adult nutritionals and demonstrate suitability through single laboratory validation. METHODS: Reducing oligosaccharides are labeled with 2-aminobenzamide (2AB), separated by hydrophilic interaction LC, and determined assuming that all oligosaccharides give an equimolar response in the detector. The same sample is analyzed a second time after treatment with β-galactosidase to remove GOS. The difference in the determined oligosaccharides between the two measurements will be the GOS content of the sample. The method was validated in a single laboratory on infant formula and adult nutritionals. RESULTS: Recoveries were in the range 91.5–102%, relative standards of deviation (RSD(r)) were in the range 0.7–5.99%, and one sample had an RSD(r) of 8.30%. Except for the one sample with an RSD(r) of 8.30%, the performance is within the requirements outlined in the Standard Method Performance Requirements, which specifies recoveries in the range 90–110% and RSD(r) of below 6%. CONCLUSIONS: The method is suitable for the determination of GOS in infant formula and adult nutritionals. HIGHLIGHTS: A method has been developed which is suitable for the determination of GOS in products with a high background concentration of lactose (infant fromula and adult nutritionals). The method does not require access to the GOS ingredient used for the production of the finished product. It is also possible to separately quantify the amount of GOS containing three or more monomeric units in order to support dietary fibre analysis.
format Online
Article
Text
id pubmed-8824811
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88248112022-02-09 Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01 Cuany, Denis Andetsion, Fikrey Fontannaz, Xavier Bénet, Thierry Spichtig, Véronique Austin, Sean J AOAC Int Human Nutrient Methods BACKGROUND: β-Galactooligosaccharides (GOS) are typically used in infant formula and adult nutritionals as a source of nondigestible oligosaccharides, which may bring beneficial effects through modulation of the gut microbiota. However, suitable methods for the determination of GOS in products with a high background of lactose do not exist. OBJECTIVE: The aim of this work was to develop a method suitable for the determination of GOS in infant formula and adult nutritionals and demonstrate suitability through single laboratory validation. METHODS: Reducing oligosaccharides are labeled with 2-aminobenzamide (2AB), separated by hydrophilic interaction LC, and determined assuming that all oligosaccharides give an equimolar response in the detector. The same sample is analyzed a second time after treatment with β-galactosidase to remove GOS. The difference in the determined oligosaccharides between the two measurements will be the GOS content of the sample. The method was validated in a single laboratory on infant formula and adult nutritionals. RESULTS: Recoveries were in the range 91.5–102%, relative standards of deviation (RSD(r)) were in the range 0.7–5.99%, and one sample had an RSD(r) of 8.30%. Except for the one sample with an RSD(r) of 8.30%, the performance is within the requirements outlined in the Standard Method Performance Requirements, which specifies recoveries in the range 90–110% and RSD(r) of below 6%. CONCLUSIONS: The method is suitable for the determination of GOS in infant formula and adult nutritionals. HIGHLIGHTS: A method has been developed which is suitable for the determination of GOS in products with a high background concentration of lactose (infant fromula and adult nutritionals). The method does not require access to the GOS ingredient used for the production of the finished product. It is also possible to separately quantify the amount of GOS containing three or more monomeric units in order to support dietary fibre analysis. Oxford University Press 2021-07-22 /pmc/articles/PMC8824811/ /pubmed/34293126 http://dx.doi.org/10.1093/jaoacint/qsab095 Text en © AOAC INTERNATIONAL 2021. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Human Nutrient Methods
Cuany, Denis
Andetsion, Fikrey
Fontannaz, Xavier
Bénet, Thierry
Spichtig, Véronique
Austin, Sean
Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
title Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
title_full Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
title_fullStr Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
title_full_unstemmed Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
title_short Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
title_sort determination of β-galactooligosaccharides (gos) in infant formula and adult nutritionals: single-laboratory validation, first action 2021.01
topic Human Nutrient Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824811/
https://www.ncbi.nlm.nih.gov/pubmed/34293126
http://dx.doi.org/10.1093/jaoacint/qsab095
work_keys_str_mv AT cuanydenis determinationofbgalactooligosaccharidesgosininfantformulaandadultnutritionalssinglelaboratoryvalidationfirstaction202101
AT andetsionfikrey determinationofbgalactooligosaccharidesgosininfantformulaandadultnutritionalssinglelaboratoryvalidationfirstaction202101
AT fontannazxavier determinationofbgalactooligosaccharidesgosininfantformulaandadultnutritionalssinglelaboratoryvalidationfirstaction202101
AT benetthierry determinationofbgalactooligosaccharidesgosininfantformulaandadultnutritionalssinglelaboratoryvalidationfirstaction202101
AT spichtigveronique determinationofbgalactooligosaccharidesgosininfantformulaandadultnutritionalssinglelaboratoryvalidationfirstaction202101
AT austinsean determinationofbgalactooligosaccharidesgosininfantformulaandadultnutritionalssinglelaboratoryvalidationfirstaction202101